These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9467502)

  • 1. Constitutional chromosomal instability: a case with three primary and sequential cancers.
    Carrasco N; Casadevall C; Bernues M; Nohales GL; Gelabert-Mas A
    Br J Urol; 1998 Jan; 81(1):172. PubMed ID: 9467502
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome instability in lymphocytes from two patients affected by three sequential primary cancers: the role of fragile sites.
    Ribas M; Miró R; Gelabert A; Egozcue J
    Cancer Genet Cytogenet; 1999 Apr; 110(2):133-5. PubMed ID: 10214362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitance of urogenital with lymphoid and intestinal malignancies: more than a coincidence.
    Shabtai F; Lask D; Kimchi D; Hart J; Halbrecht I
    Urol Int; 1985; 40(3):145-7. PubMed ID: 4040290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer.
    Ong E; Joseph JV; Bramwell SP; Haites NE
    BJU Int; 2003 Feb; 91(3):297. PubMed ID: 12581024
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Vanni R; Scarpa RM
    Cancer Res; 1986 Sep; 46(9):4873. PubMed ID: 3731134
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial urinary bladder cancer.
    Purtilo DT; McCarthy B; Yang JP; Friedell GH
    Semin Oncol; 1979 Jun; 6(2):254-6. PubMed ID: 482963
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
    Lunec J; Challen C; Wright C; Mellon K; Neal DE
    Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial transitional cell carcinoma of the bladder.
    McCullough DL; Lamma DL; McLaughlin AP; Gittes RF
    J Urol; 1975 May; 113(5):629-35. PubMed ID: 1127804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial carcinoma of ureters and other genitourinary organs.
    Marchetto D; Li FP; Henson DE
    J Urol; 1983 Oct; 130(4):772-3. PubMed ID: 6887416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic aberrations in bladder carcinoma.
    Roy JB; Dagg K; Bottomley R
    Mil Med; 1984 Nov; 149(11):622-3. PubMed ID: 6438554
    [No Abstract]   [Full Text] [Related]  

  • 13. Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure.
    Chen PC; Chen WC; Chao SC; Lin BW; Lin SC; Chen CJ; Lee JC
    J Surg Oncol; 2012 Mar; 105(3):329-30. PubMed ID: 21882197
    [No Abstract]   [Full Text] [Related]  

  • 14. The genetics of bladder cancer: a cytogeneticist's perspective.
    Wolff DJ
    Cytogenet Genome Res; 2007; 118(2-4):177-81. PubMed ID: 18000368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal analysis as prognostic tool in transitional cell carcinoma: preliminary report.
    Gonick P; Kalathoor R; Fuscaldo K
    Urology; 1980 Nov; 16(5):527-9. PubMed ID: 7445296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome markers and progression in bladder cancer.
    Sandberg AA
    Cancer Res; 1977 Aug; 37(8 Pt 2):2950-6. PubMed ID: 872125
    [No Abstract]   [Full Text] [Related]  

  • 17. A squamous cell bladder carcinoma with karyotypic abnormalities reminiscent of transitional cell carcinoma.
    Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
    J Urol; 1989 Aug; 142(2 Pt 1):374-6. PubMed ID: 2746756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
    Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
    Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
    Panani AD; Ferti AD; Raptis SA; Roussos C
    Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.